Blog

What we learned at Phoenix UGM at Certainty 2026 about the future of PK/PD

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 5 月 8 日 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…

Certara2026 年 5 月 8 日

On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…

Certara2026 年 5 月 6 日

Blog

GxP compliance in the cloud: What IT teams need to rethink

Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…

Certara2026 年 5 月 4 日

Webinar

Allometric Approach in pharmacokinetics when and how to use it

Danielle Pillsbury2026 年 4 月 28 日

Webinar

When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy

Certara2026 年 4 月 10 日

Blog

PK parameters explained: From Cmax to clearance (and why it matters for development decisions)

Learn how key PK parameters such as Cmax, AUC, clearance, half life, and volume of…

Certara2026 年 4 月 9 日

On-Demand Webinar

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Watch this on-demand webinar to learn how the final ICH M15 guidance is shaping Model-Informed…

Certara2026 年 4 月 2 日

Case Study

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…

Certara2026 年 3 月 26 日

Publication

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

This study evaluated the pharmacokinetics (PK) and pharmacokinetic–pharmacodynamic (PK–PD) relationship of clazakizumab, an anti–interleukin-6 (IL-6)…

Danielle Pillsbury2026 年 3 月 24 日

Guide

From Numbers to Narrative: Mastering the Art of PK Presentation

Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…

Certara2026 年 3 月 20 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara Products – Phoenix

What we learned at Phoenix UGM at Certainty 2026 about the future of PK/PD

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

GxP compliance in the cloud: What IT teams need to rethink

Allometric Approach in pharmacokinetics when and how to use it

When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy

PK parameters explained: From Cmax to clearance (and why it matters for development decisions)

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

From Numbers to Narrative: Mastering the Art of PK Presentation

订阅时事通讯

快捷链接

解决方案

联系我们